Faced with a dire shortage of medicines, supplies and medical personnel despite the authorities’ claims about the quality of ...

Harsoria said it will use the funding to expand its manufacturing capabilities, improve research and development (R&D) ...

There is currently no cure for FSGS, which is the leading cause of kidney failure in children, and 5,400 patients are diagnosed with it every year. While 1,000 patients receive kidney transplants ...

Adequate vascular access is essential for patients undergoing hemodialysis. When possible, the creation of an arteriovenous fistula using native veins will provide the highest long-term patency and ...

Autologous arteriovenous access is the key to long-term success with hemodialysis and is strongly supported by the National Kidney Foundation's Dialysis Outcomes Quality Initiative guidelines.

An infected urachal cyst can also lead to what's known as an enteric fistula, in which an abnormal connection forms ... you may need to get antibiotics through a vein in your arm (intravenous).

For example, a 5/1 ARM will have the same rate for the first five years, then can adjust each year after that—meaning the rate might go up or down, based on the market. An ARM isn’t for everyone.

Check out today's ARM rates to see how rates are currently trending. What are current ARM rates? In December, 7/1 ARM rates and 5/1 ARM rates averaged around 6.53% and 6.69%, respectively ...

Ampere has drawn interest from Arm while exploring its strategic options, the person said, adding that the talks could still not eventually materialise. The news was first reported by Bloomberg News.

We expect Arm will keep gaining market share in the data center from x86 architecture, as its chips consume less power and data centers need to minimize energy consumption. We also expect share ...